주식/증권
📈 긍정적
관련 뉴스
Profound outlines ~$25M 2026 revenue, anticipates FDA clearance for Siemens Free integration by year-end
05/08/2026
Allient outlines $12M-$15M FY2026 CapEx while aiming to complete Dothan transition by end of Q3
05/08/2026
Phibro outlines FY2026 net sales of $1.46B-$1.5B as adjusted EBITDA guidance moves to $247M-$255M
05/08/2026
Arrowhead anticipates SHASTA-3/4 topline in Q3 while planning an SHTG sNDA before end of 2026
05/08/2026